Non-small-cell lung cancer: Multimodality approach in stage-III resectable disease

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Thomas, Michael ^a   Hoffknecht, Petra ^a   Droege, Cornelia ^a   Baisch, Andreas ^a   Reinmuth, Niels ^a   Kreuter, Michael ^a   Lange, Tobias ^a   Berdel, Wolfgang E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Multimodality treatment with surgery; Non small cell lung cancer; Stage III disease

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE;

BEAM THERAPY; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; ESOPHAGITIS; HAZARD ASSESSMENT; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MEDICAL ASSESSMENT; PNEUMONIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING;

EID: 8444233332     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.985     Document Type: Conference Paper

References (31)

1. van Raemdonck D.E., Schneider A., and Ginsberg R.J. Surgical treatment for higher stage non-small cell lung cancer Ann Thorac Surg 54 1992 999 1013
2. 3) non-small cell lung cancer J Thorac Cardiovasc Surg 122 2001 796 802
3. Grunenwald D., and Le Chevalier T. Stage III A category of nonsmall cell lung cancer: A new proposal J Natl Cancer Inst 98 1997 88 89
4. Robinson L., Wagner H., and Ruckdeschel J. Treatment of stage III A non-small cell lung cancer Chest 123 2003 202S 220S
5. Andre F., Grunenwald D., and Pignon J.P. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications J Clin Oncol 18 2000 2981 2989
6. Bunn P.A. The treatment of non-small cell lung cancer: Current perspectives and controversies, future directions Semin Oncol 21 1994 49 59
7. NSCLC Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials Br Med J 311 1995 899 909
8. Keller S.M., Dudeshna A., and Wagner H. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer N Engl J Med 343 2000 1217 1222
9. Scagliotti V., Fossati R., Torri V. Adjuvant Lung Project Italy/European Organisation for Research and Treatment of Cancer Lung Cooperative Group Investigator Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
10. The International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer N Engl J Med 350 2004 351 360
11. Spira A., and Ettinger D. Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392
12. Blum R. Adjuvant chemotherapy for lung cancer -- a new standard of care N Engl J Med 350 2004 404 405
13. Rosell R., Gomez-Codina J., and Camps C. A randomized trial comparing pre-operative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158
14. Rosell R., Gomez-Codina J., and Camps C. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7 year ass;ment of a randomized controlled trial Lung Cancer 26 1999 7 14
15. Roth J.A., Fossela F., and Komaki R. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 1994 673 680
16. Roth J.A., Atkinson E.N., and Fossella F. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer Lung Cancer 21 1998 1 6
17. Pass H.I., Progrebniak H.W., and Steinberg S.M. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis Ann Thorac Surg 53 1992 992 998
18. Depierre A., Milleron B., and Moro-Sibilot D. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (accept T1 N0), II, and III a non-small cell lung cancer J Clin Oncol 20 2002 247 253
19. Albain K., Rusch V., and Crowley J. Concurrent cysplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Major mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
20. Choi N., Carey R., and Daly W. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer J Clin Oncol 15 1997 712 722
21. Eberhardt W., Wilke H., and Stamatis G. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial J Clin Oncol 16 1998 622 634
22. Thomas M., Rübe C., and Semik M. Chemotherapy and subsequent twice-daily chemoradiation before surgery in stage III non-small cell lung cancer: impact of tumor regression on survival J Clin Oncol 17 1999 1185 1193
23. Abstract 1742 Splinter T., Kirkpatrick A., and van Meerbeeck J. Randomized trial of surgery versus radiotherapy in patients with stage IIIA non-small-cell lung cancer after response to induction chemotherapy. Intergroup study 08941 Proc Am Soc Clin Oncol 17 1998 453
24. 2) non small cell lung cancer (NSCLC): Initial results from intergroup trial 0139 (RTOG 93-09) Proc Am Soc Clin Oncol 22 2003 621A
25. Stamatis G. Personal communication. 2003.
26. 2 non-small-cell lung cancer: A multicenter phase II-trial J Clin Oncol 21 2003 1752 1759
27. Abstract 1108 Fleck J., Camargo D., and Godoy P. Chemoradiation therapy versus chemotherapy alone as a neoadjuvant treatment of stage III non-small cell lung cancer (NSCLC). Preliminary report of a phase III prospective randomized trial Proc Am Soc Clin Oncol 12 1993 333a
28. Abstract 7004 Thomas M., Macha H., Ukena D. German Lung Cancer Cooperative Group (2004) Cisplatin/etoposide (PE) followed by twice-daily chemoradiation (hfRT/CT) versus PE alone before surgery in stage III non-small cell lung cancer (NSCLC): a randomized phase III trial of the German Lung Cancer Cooperative Group (GLCCG) Proc Am Soc Clin Oncol 23 2004 616
29. Stuschke M., Eberhardt W., and Pöttgen C. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects J Clin Oncol 17 1999 2700 2709
30. Law A., Karp D., and Dipetrillo T. Emergence of increased cerebral metastases after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced non-small cell lung carcinoma Cancer 92 2001 160 164
31. Vokes E., and Choy H. Targeted therapies for stage III nonsmaLL cell lung cancer: integration in the combined modality setting Lung Cancer 41 Suppl. 1 2003 S115 S121